Stem Cells Inc. Joining with LaFerla on Alzheimer's Effort
Stem Cells Inc. of Newark, Ca., this morning touted its research award from the California stem cell agency as an "encouraging vote of confidence" for its plans to develop a stem cell-based therapy for Alzheimer's disease.
In a widely distributed news release, Ann Tsukamoto, executive vice president of the publicly traded company said,
"Our research, and…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.